Comment on

• TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.

  Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. Grube E, et al. Circulation. 2003 Jan 7;107(1):38-42. doi: 10.1161/01.cir.0000047700.58683.a1. Circulation. 2003. PMID: 12515740 Clinical Trial.
• Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

  Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RH. Hannan EL, et al. N Engl J Med. 2008 Jan 24;358(4):331-41. doi: 10.1056/NEJMoa071804. N Engl J Med. 2008. PMID: 18216353